Fri, August 11, 2023
Thu, August 10, 2023
Wed, August 9, 2023

Robert Driscoll Reiterated (ACET) at Buy and Held Target at $17 on, Aug 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-17-on-aug-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Robert Driscoll of Wedbush, Reiterated "Adicet Bio, Inc." (ACET) at Buy and Held Target at $17 on, Aug 10th, 2023.

Robert has made no other calls on ACET in the last 4 months.



There are 4 other peers that have a rating on ACET. Out of the 4 peers that are also analyzing ACET, 3 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Schmidt of "Guggenheim" Downgraded from Strong Buy to Hold and Held Target at $20 on, Tuesday, June 27th, 2023
  • Reni Benjamin of "JMP Securities" Downgraded from Buy to Hold on, Tuesday, June 27th, 2023
  • Brian Cheng of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $6 on, Thursday, June 1st, 2023


This is the rating of the analyst that currently disagrees with Robert


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $38 on, Tuesday, June 27th, 2023

Publication Contributing Sources